control
influenza
viru
infect
human
continu
present
major
challeng
season
influenza
epidem
account
annual
averag
approxim
death
hospit
unit
state
addit
occasion
influenza
pandem
extens
worldwid
morbid
mortal
featur
human
histori
salomon
webster
ongo
influenza
threat
consequ
period
emerg
variant
virus
diminish
suscept
preexist
abmedi
immun
human
popul
subbarao
joseph
vaccin
provid
effect
strategi
protect
season
pandem
influenza
vaccin
formul
manufactur
alway
playpomegran
compon
viral
envelop
glycoprotein
block
interact
cell
receptor
inhibit
infect
chemic
natur
activ
compon
defin
neurath
et
al
studi
polyphenol
compound
deriv
rang
plant
speci
demonstr
antivir
effect
dna
rna
virus
indic
potenti
broad
spectrum
antivir
activ
nakayama
et
al
schnitzler
et
al
serkedjieva
manolova
weiss
et
al
evid
plant
pp
exert
antivir
effect
interact
directli
viral
particl
nakayama
et
al
schnitzler
et
al
song
et
al
although
extent
pp
bind
viral
surfac
compon
may
influenc
natur
viru
serkedjieva
plant
pp
may
also
exert
antivir
effect
intracellular
replic
palamara
et
al
part
may
due
pp
oppos
prooxid
state
induc
cell
replic
virus
fraternal
et
al
high
level
divers
polyphenol
compound
pomegran
suggest
fruit
may
rich
sourc
molecul
exert
antivir
activ
via
multipl
mechan
recent
evid
present
pomegran
pp
directli
virucid
influenza
virus
also
act
intracellular
level
inhibit
influenza
viru
replic
haidari
et
al
current
studi
focus
direct
antiinfluenza
viru
activ
pomegran
extract
demonstr
influenza
virus
repres
divers
subtyp
suscept
rapid
inactiv
compon
pp
fraction
pomegran
howev
suscept
inactiv
differ
reassort
virus
indic
modul
rel
small
chang
virion
surfac
glycoprotein
find
also
indic
inactiv
primarili
consequ
ppinduc
virion
structur
damag
extract
prepar
californiagrown
process
wonder
varieti
pomegran
suppli
pom
wonder
lo
angel
ca
three
form
commerci
avail
extract
use
pomegran
juic
pj
pomegran
liquid
extract
pomxl
pomegran
pp
powder
extract
pomxp
prepar
pomegran
extract
colorimetr
determin
phenol
content
predominantli
pomegran
pp
describ
elsewher
aviram
et
al
heber
et
al
total
phenol
content
extract
express
g
gallic
acid
equival
estim
gml
pj
gml
pomxl
gmg
pomxp
aviram
et
al
experi
perform
use
follow
influenza
virus
apuerto
reassort
viru
express
background
kilbourn
et
al
main
et
al
iv
anew
strain
circul
human
popul
unit
state
approxim
past
year
wood
influenza
viru
stock
grown
allanto
caviti
embryon
hen
egg
titer
infecti
viru
measur
tissu
cultur
infect
dose
tcid
titrat
madin
darbi
canin
kidney
mdck
cell
viral
titrat
grown
mem
lglutamin
mm
penicillin
iuml
streptomycin
gml
gentamicin
gml
supplement
fb
confluent
mdck
cell
monolay
tissu
cultur
plate
wash
serumfre
mem
use
serial
dilut
viru
serumfre
mem
contain
bsa
gml
l
tosylamido
ethyl
chloromethyl
keton
tpck
treat
trypsin
worthington
lakewood
nj
prepar
replic
well
mdck
monolay
l
total
volum
per
well
incub
day
c
co
well
posit
viru
growth
identifi
presenc
hemagglutin
hag
activ
supernat
tcid
titer
calcul
method
reed
muench
mous
hepat
viru
mhv
obtain
dr
david
brian
univers
tennesse
knoxvil
tn
grown
rat
lung
epitheli
rle
cell
cultur
dmem
lglutamin
mm
hepe
mm
gentamicin
gml
supplement
fb
determin
viral
titer
plaqu
assay
serial
dilut
viru
cell
cultur
medium
ad
wash
rle
cell
monolay
tissu
cultur
plate
lwell
plate
incub
h
c
allow
viral
adsorpt
well
wash
agaros
overlay
agaros
mem
supplement
lglutamin
gentamicin
nonessenti
amino
acid
fb
ad
allow
set
plate
incub
invert
c
co
cell
monolay
fix
formaldehyd
stain
coomassi
blue
visual
viral
plaqu
pj
pomxl
test
rang
concentr
pb
pomxp
dissolv
pb
pp
concentr
mgml
mgml
pomxp
pass
diamet
filter
dilut
pb
test
influenza
virus
tcid
ml
unless
specifi
combin
differ
concentr
pj
pomxl
incub
min
room
temperatur
immedi
follow
incub
titer
infecti
viru
determin
tcid
assay
mdck
cell
control
antivir
effect
due
sole
ph
viru
treat
parallel
citratephosph
buffer
match
ph
test
solut
pj
pomxl
similar
strategi
use
evalu
antiinfluenza
activ
differ
concentr
pomxp
express
pp
concentr
control
possibl
effect
low
pp
concentr
cell
cultur
medium
incub
tcid
assay
untreat
influenza
virus
titrat
well
contain
pp
concentr
match
well
titrat
pomxptreat
virus
rang
concentr
pomxp
gml
pp
dilut
cell
cultur
medium
mdck
cell
monolay
replic
well
influenza
virus
tcid
ml
dilut
well
media
well
immedi
serial
dilut
replic
well
mdck
cell
monolay
plate
incub
tcid
titer
determin
describ
activ
pomxp
mhv
pfuml
test
describ
influenza
viru
except
infecti
viral
titer
treatment
determin
plaqu
assay
effect
pomxp
mdck
cell
viabil
evalu
use
mtt
cell
prolifer
assay
kit
atcc
manassa
va
accord
manufactur
instruct
briefli
confluent
mdck
cell
monolay
wash
cultur
medium
contain
pomxp
concentr
gml
pp
ad
triplic
well
lwell
h
incub
cell
monolay
wash
l
cultur
medium
contain
l
mtt
reagent
ad
well
plate
held
c
incub
h
lwell
deterg
reagent
ad
overnight
incub
room
temperatur
absorb
nm
read
use
biotek
synergi
micropl
reader
hag
activ
influenza
virus
also
evalu
immedi
treatment
differ
concentr
pomxp
describ
serial
dilut
treat
viru
prepar
pb
roundbottom
plate
lwell
equal
volum
chicken
rbc
resuspend
pb
bsa
ad
well
plate
briefli
agit
hemagglutin
hag
score
min
incub
room
temperatur
investig
whether
pp
present
hag
assay
interact
rbc
surfac
molecul
inhibit
virusmedi
hag
efficaci
pomxptreat
rbc
hag
assay
assess
rbc
mix
rang
concentr
pomxp
gml
pp
incub
room
temperatur
min
singl
gentl
wash
rbc
resuspend
concentr
pb
bsa
pomxpand
pbstreat
rbc
use
determin
titer
influenza
describ
pomxp
alon
pp
concentr
mgml
hag
activ
assay
perform
presenc
bsa
case
experi
absenc
bsa
pp
concentr
greater
approxim
gml
inher
hag
activ
modifi
elisa
sangster
et
al
use
evalu
inhibit
bind
virusspecif
ab
pp
briefli
elisa
plate
coat
gwell
sucrosegradi
purifi
detergentdisrupt
viru
block
bsa
pb
wash
serial
dilut
pomxp
solut
start
mgml
prepar
pb
ad
plate
triplic
well
lwell
plate
incub
room
temperatur
h
wash
pb
virusspecif
ab
dilut
pbstween
bsa
ad
appropri
well
lwell
ab
prepar
use
concentr
gave
absorb
approxim
absenc
pp
inhibit
plate
incub
h
wash
bound
ab
detect
alkalin
phosphataseconjug
goat
antimous
igg
goat
antirabbit
igg
southern
biotechnolog
associ
birmingham
al
follow
pnitrophenyl
phosphat
substrat
absorb
nm
read
use
micropl
reader
virus
use
influenza
virus
mhv
virusspecif
ab
influenzaspecif
mab
rabbit
antiserum
rais
mhv
kindli
provid
dr
mark
denison
vanderbilt
univers
nashvil
tn
control
nonspecif
ab
adher
pptreat
virus
analysi
also
perform
use
plate
coat
influenza
influenza
virus
mhv
treat
min
room
temperatur
gml
pp
neg
stain
examin
transmiss
electron
microscopi
untreat
control
viru
incub
pb
immedi
treatment
sampl
adsorb
freshli
glowdischarg
collodion
carbon
film
mesh
copper
grid
stain
phosphotungst
acid
examin
hitachi
electron
microscop
kv
group
mean
compar
use
twotail
mannwhitney
u
test
unpair
sampl
conting
tabl
analys
involv
proport
normal
aberr
virion
perform
use
twosid
fisher
exact
test
test
perform
use
graphpad
softwar
san
diego
ca
valu
p
consid
statist
signific
initi
experi
test
pj
pomxl
direct
antivir
activ
influenza
viru
treat
min
room
temperatur
differ
concentr
pj
pomxl
titer
infecti
viru
determin
immedi
thereaft
titer
consist
lower
pj
pomxp
treatment
compar
ph
control
suggest
antivir
activ
distinct
effect
ph
alon
howev
differ
signific
pomxl
fig
b
ident
approach
use
evalu
antiinfluenza
activ
ppenrich
pomxp
exposur
influenza
gml
pp
rapidli
reduc
infect
titer
lower
log
gml
fig
determin
whether
pomegran
pp
antivir
activ
influenza
subtyp
evalu
activ
pomxp
solut
case
infect
rapidli
elimin
treatment
gml
pp
fig
titer
decreas
incub
control
buffer
match
ph
gml
pp
respect
data
shown
tcid
assay
routin
appli
measur
titer
infecti
influenza
viru
pomxp
treatment
perform
incub
serial
dilut
treat
viru
day
replic
well
mdck
cell
monolay
low
concentr
pp
therefor
present
well
incub
assay
could
potenti
affect
viral
titer
block
viral
replic
cellular
level
haidari
et
al
reduc
mdck
cell
viabil
seeram
et
al
one
set
experi
control
preincub
differ
pomxp
concentr
prior
tcid
titrat
omit
instead
virus
first
combin
pomxp
dilut
prepar
mdck
cell
monolay
tcid
titrat
essenti
approach
titrat
untreat
virus
well
contain
pp
concentr
match
well
titrat
pomxptreat
virus
tcid
titer
ident
measur
use
ppfree
cultur
medium
data
shown
indic
antivir
activ
describ
pomxp
reflect
effect
tcid
titrat
furthermor
analysi
mtt
assay
indic
h
incub
mdck
cell
gml
pp
maximum
pp
concentr
well
tcid
titrat
pomxptreat
virus
treat
min
room
temperatur
differ
concentr
pj
pomxl
b
phmatch
buffer
infecti
viru
titer
treatment
determin
assay
result
shown
fold
reduct
titer
rel
untreat
viru
incub
pb
data
mean
sd
separ
experi
p
advers
effect
cell
viabil
strategi
minim
effect
pp
tcid
titrat
pomxptreat
incub
mdck
monolay
h
allow
viral
adsorpt
plate
wash
ppfree
cultur
medium
ad
durat
assay
result
match
shown
fig
b
taken
togeth
find
demonstr
direct
interact
pomegran
pp
viral
particl
respons
potent
antivir
activ
influenza
virusinduc
hag
result
bind
viral
hemagglutinin
ha
sialic
acid
residu
rbc
surfac
molecul
reflect
rbc
crosslink
intact
virion
determin
effect
pomxp
treatment
hag
activ
viral
prepar
treat
describ
analysi
effect
viral
infect
hag
titer
measur
immedi
follow
incub
viru
pomxp
solut
loss
hag
activ
accompani
loss
infect
fig
b
rais
possibl
pp
interact
viral
ha
loss
virion
integr
investig
whether
pp
present
hag
assay
bound
mask
rbcassoci
sialic
acid
render
rbc
resist
virusinduc
hag
hag
titer
determin
use
rbc
pretreat
pomxp
pomxptreat
rbc
gave
hag
titer
pbstreat
rbc
total
result
indic
loss
viral
hag
activ
pomxp
treatment
reflect
direct
preferenti
interact
pp
viral
particl
activ
pomxp
unrel
rna
viru
evalu
use
coronaviru
mhv
titer
infecti
mhv
reduc
pp
concentr
gml
fig
antivir
effect
markedli
less
influenza
viru
treatment
compar
viral
concentr
gml
pp
reduc
titer
approxim
log
reduct
mhv
titer
approxim
log
suggest
antivir
activ
virusspecif
analysi
pomxp
demonstr
potent
antivir
activ
two
longestablish
standard
laboratori
strain
influenza
viru
import
question
whether
antivir
activ
would
evid
influenza
virus
display
divers
envelop
glycoprotein
sinc
chang
molecul
typifi
emerg
influenza
virus
threaten
human
health
investig
pomxp
activ
test
reassort
influenza
virus
express
ha
neuraminidas
na
molecul
isol
isol
recent
pandem
viru
swine
origin
nonha
na
compon
reassort
deriv
compar
effect
fig
b
pomxp
treatment
result
minor
reduct
infect
howev
infect
markedli
reduc
resembl
effect
pomxp
fig
thu
suscept
variant
subtyp
virus
pp
treatment
modul
natur
express
ha
na
treatment
suffici
high
concentr
pomxp
complet
elimin
infect
virus
fig
f
particularli
suscept
titer
reduc
log
gml
pp
pomxp
treatment
littl
effect
hag
activ
result
consist
minor
effect
pomxp
infect
virus
howev
hag
activ
also
lost
treatment
pp
concentr
complet
elimin
infect
suggest
effect
infect
simpli
consequ
pp
coat
viral
particl
surprisingli
hag
activ
lost
treatment
gml
pp
treatment
higher
pp
concentr
elimin
infect
overal
find
indic
effect
pp
exposur
hag
activ
predictor
effect
infect
howev
cautiou
interpret
warrant
pomxp
hag
activ
assay
perform
absenc
bsa
possibl
predict
consequ
potenti
multidirect
interact
pptreat
virus
combin
rbc
bsa
solut
experi
describ
section
test
parallel
ensur
reproduc
earlier
find
result
match
shown
fig
elisabas
ab
inhibit
assay
use
investig
whether
pomxp
treatment
result
coat
virion
surfac
compon
pomxp
treatment
platebound
influenza
inhibit
bind
mab
specif
fig
interestingli
inhibitori
effect
plateau
high
pp
concentr
complet
inhibit
mab
bind
achiev
residu
bind
due
specif
mabligand
interact
sinc
mab
bound
control
experi
use
platebound
instead
pomxp
treatment
also
inhibit
bind
mab
platebound
fig
fig
notabl
analysi
clearli
discrimin
two
influenza
virus
suscept
resist
respect
effect
pomxp
treatment
assess
infect
hag
assay
compar
fig
thu
impress
pp
effect
influenza
viru
infect
hag
activ
simpli
reflect
extent
mask
viral
surfac
compon
bound
pp
pomxp
treatment
platebound
mhv
result
inhibit
bind
virusspecif
polyclon
antiserum
fig
howev
less
mark
high
pp
concentr
compar
analysi
influenza
virus
describ
suggest
rel
resist
mhv
antivir
activ
pomxp
may
part
reflect
decreas
pp
bind
viral
compon
gain
insight
mechan
antivir
activ
virus
examin
transmiss
electron
microscopi
treatment
gml
pp
analysi
focus
highli
suscept
inactiv
pp
concentr
mhv
rel
resist
pp
treatment
mhv
significantli
increas
proport
aberr
virion
tabl
high
proport
particl
show
aberr
morpholog
treatment
interestingli
morpholog
chang
differ
treat
particl
featur
widespread
loss
order
arrang
definit
envelop
glycoprotein
well
envelop
irregular
break
appear
envelop
glycoprotein
suggest
interact
extran
materi
fig
b
contrast
high
titer
viral
prepar
examin
min
incub
pb
untreat
gml
pp
treat
b
criteria
score
aberr
virion
base
comparison
major
untreat
virion
envelop
break
irregular
influenza
virus
disorgan
loss
definit
envelop
glycoprotein
result
pool
least
separ
experi
viru
c
treat
vs
untreat
p
treat
vs
treat
p
treat
vs
treat
p
treat
particl
show
vari
degre
fragment
envelop
glycoprotein
unaffect
part
virion
remain
order
rel
welldefin
fig
proport
aberr
virion
pp
treatment
significantli
smaller
compar
tabl
correl
rel
resist
inactiv
pp
morpholog
chang
aberr
virion
gener
resembl
virion
fig
f
treatment
mhv
effect
virion
structur
base
sole
appear
virion
envelop
howev
surfac
glycoprotein
spike
mhv
occasion
less
abund
pp
treatment
fig
h
gener
tendenc
pptreat
virion
aggreg
may
contribut
reduct
infect
overal
electron
microscop
analysi
indic
antivir
effect
pp
mediat
differ
way
depend
natur
viru
case
influenza
viru
observ
suggest
elimin
infect
pp
primarili
consequ
damag
virion
integr
rather
simpli
coat
viral
particl
analysi
add
grow
bodi
literatur
describ
antivir
activ
pp
prepar
deriv
plant
show
pp
compon
pomegran
rapidli
inactiv
influenza
viru
direct
effect
viral
particl
antivir
activ
pomegran
pp
potent
influenza
virus
reassort
viru
previou
studi
demonstr
antiinfluenza
activ
pp
plant
sourc
provid
evid
direct
interact
pp
viral
ha
na
nagai
et
al
nakayama
et
al
roschek
et
al
serkedjieva
manolova
song
et
al
also
like
pomegran
pp
sinc
treatment
influenza
virus
pomxp
reduc
bind
haand
naspecif
mab
unclear
whether
pp
interact
viral
surfac
glycoprotein
significantli
modifi
molecular
structur
antigen
determin
simpli
establish
coat
imped
access
numer
studi
evalu
effect
varieti
pp
prepar
influenza
virus
demonstr
associ
loss
infect
loss
hag
activ
consist
pp
interact
viral
ha
haidari
et
al
nagai
et
al
nakayama
et
al
serkedjieva
manolova
song
et
al
also
case
gener
enzymeconjug
secondari
ab
substrat
analysi
also
perform
use
plate
coat
influenza
control
nonspecif
adher
ab
point
repres
mean
sd
triplic
well
result
repres
two
separ
experi
gave
similar
result
studi
use
particular
fig
b
howev
reassort
pomxp
treatment
elimin
infect
without
loss
hag
activ
fig
e
suggest
mechan
viral
inactiv
addit
interfer
ha
function
pp
prepar
deriv
plant
shown
vari
activ
differ
influenza
subtyp
well
variant
virus
subtyp
serkedjieva
analysi
pomegran
pp
effect
reduc
infect
reassort
viru
effect
much
smaller
three
reassort
particular
fig
although
pomxp
treatment
littl
effect
infect
hag
activ
still
reduc
bind
mab
fig
suggest
pp
interact
directli
ha
virus
far
suscept
pomxp
inactiv
electron
microscop
analysi
pomxptreat
virus
identifi
clear
morpholog
abnorm
virus
suscept
inactiv
wherea
chang
less
frequent
rel
resist
fig
taken
togeth
find
indic
pomegran
pp
bind
divers
influenza
viru
predict
viral
inactiv
appar
mechan
result
structur
damag
virion
respons
elimin
infect
distinct
appear
pomxptreat
examin
electron
microscopi
fig
consist
multipl
mechan
viral
inactiv
rais
possibl
mechan
may
vari
even
rel
similar
virus
part
find
consist
recent
analysi
antivir
activ
hydroxytyrosol
small
phenol
deriv
major
polyphenol
compon
oliv
tree
inactiv
differ
influenza
viru
subtyp
direct
exposur
hydroxytyrosol
associ
damag
virion
integr
ha
na
function
unaffect
yamada
et
al
find
reassort
viral
compon
common
except
ha
na
identifi
ha
na
key
determin
suscept
influenza
virus
inactiv
pomegran
pp
furthermor
rel
small
chang
molecul
modul
suscept
like
chang
viral
surfac
glycoprotein
influenc
reactiv
pp
unclear
may
relat
damag
virion
integr
antivir
mechan
appar
involv
direct
indirect
effect
viral
envelop
sinc
envelop
virus
consid
suscept
nonenvelop
virus
kotwal
recent
haidari
et
al
analyz
direct
effect
pomegran
pp
extract
influenza
viru
demonstr
inactiv
associ
loss
hag
activ
extend
work
show
suscept
influenza
virus
direct
inactiv
regul
natur
surfac
glycoprotein
find
also
indic
inactiv
result
damag
virion
structur
integr
may
distinct
effect
ha
function
haidari
et
al
also
present
evid
addit
direct
virucid
effect
pomegran
pp
also
act
intracellular
step
inhibit
influenza
replic
howev
unclear
whether
mechan
intracellular
effect
distinct
direct
antivir
activ
one
possibl
antioxid
properti
pp
counter
prooxid
intracellular
environ
favor
influenza
replic
cai
et
al
interest
determin
whether
influenza
virus
resist
direct
inactiv
pomegran
pp
also
resist
intracellular
antivir
effect
pp
prepar
deriv
plant
typic
complex
mixtur
molecular
form
evid
differ
antivir
activ
individu
pp
compound
haidari
et
al
synergist
activ
pp
mixtur
song
et
al
presum
biochem
reactiv
pp
interact
protein
lipid
play
import
role
diniz
et
al
soar
et
al
within
pp
prepar
differ
pp
perhap
also
small
deriv
molecul
yamada
et
al
may
exert
antivir
activ
interact
differ
viral
compon
howev
molecular
interact
basi
antivir
activ
pp
relat
characterist
specif
pp
well
understood
song
et
al
although
pp
bind
cell
surfac
molecul
describ
williamson
et
al
evid
select
pp
reactiv
preferenti
bind
viral
compar
host
cell
molecul
nagai
et
al
deriv
avian
isol
wherea
deriv
isol
fatal
human
case
rais
possibl
featur
surfac
glycoprotein
influenza
virus
adapt
mainten
avian
reservoir
may
also
confer
resist
effect
pp
particular
may
appli
virus
maintain
duck
aquat
bird
transmiss
via
fecalor
rout
favor
viral
persist
aquat
environ
breban
et
al
pp
relat
humic
substanc
may
also
antivir
activ
anesio
et
al
kotwal
compon
natur
organ
matter
aquat
environ
chen
et
al
may
present
suffici
concentr
exert
select
pressur
influenza
virus
select
pressur
may
also
oper
gastrointestin
tract
influenzainfect
waterbird
environ
like
rich
pp
notabl
serkedjieva
demonstr
passag
influenza
viru
presenc
pp
select
decreas
sensit
pp
inhibit
import
consider
whether
pp
deriv
pomegran
plant
sourc
may
util
combat
influenza
viral
infect
analysi
complet
inactiv
suscept
influenza
viru
strain
gener
requir
treatment
approxim
gml
pp
howev
emphas
durat
treatment
min
titer
reduct
frequent
observ
gml
pp
haidari
et
al
treat
influenza
viru
min
pomegran
pp
extract
demonstr
signific
direct
antivir
activ
concentr
approxim
gml
littl
known
metabol
ingest
pp
whether
absorb
constitu
contribut
antivir
activ
bodi
benefit
pp
antivir
prophylaxi
treatment
influenza
like
optim
appli
directli
site
infect
mous
model
studi
pp
administr
lung
reduc
effect
influenza
infect
without
toxic
host
nagai
et
al
serkedjieva
et
al
interestingli
nasopharyng
administr
pomegran
extract
cuban
folk
remedi
influenza
vidal
et
al
continu
character
pp
constitu
deriv
mediat
antivir
activ
may
lead
inhal
topic
appli
prepar
aid
control
influenza
